The page is the record's research on the issuer — no analyst, no rating, no view. # Odyssey Therapeutics, Inc. (NASDAQ: ODTX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Odyssey Therapeutics, Inc., listed on NASDAQ under ticker ODTX, with ISIN US67613T1043 and LEI not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States — Delaware. Its listing status is listed, not halted. ## The disclosure read The record holds 63 filings in the twelve months to 2026-11-08, across 23 filing days. The median gap between filing days is 9.0 days. The latest filing is dated 2026-11-05, 3 days before the record date, and is of type regulatory_filing. For the exchange NASDAQ, the median cadence gap is 6.0 days, the median filings are 52, and the median latency is 5.0 days across 4359 issuers. For the sector 2836 Biological Products, (No Diagnostic Substances), the median cadence gap is 5.5 days, the median filings are 65.5, and the median latency is 4.0 days across 176 issuers. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and the auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds listing lines dated 2026-05-05 and 2026-05-07, and no delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable for this issuer, because the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter was as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page; the count is 0. ## Open research No openly published research notes were found on the record; the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001882782.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ODTX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ODTX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ODTX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp